The Asia Pacific MedTech sector is on the cusp of a transformative period, where integrating Artificial Intelligence (AI) is becoming a crucial strategic priority.
This whitepaper, developed in collaboration with The Asia Pacific Medical Technology Association (APACMed), explores the immense potential of AI to deliver next-generation, intelligent healthcare that will improve patient outcomes, enhance operational efficiencies, and drive innovation in health technologies, among other benefits.
AI is expected to drive significant advancements in medical technology in the coming decade, fundamentally revolutionising patient care and operational processes. Technologies such as AI-powered diagnostics, personalised treatments, and automation will enhance healthcare delivery and efficiency, addressing the increasing needs of an aging population and the growing prevalence of chronic diseases.
Despite the numerous growth opportunities, the industry faces substantial challenges, including limited healthcare infrastructure, low healthcare spending, and disparities in access to healthcare. The Asia Pacific MedTech industry has a critical role in addressing these challenges and empowering transformation in the form of intelligent healthcare using AI. The MedTech ecosystem can set new industry standards, influence AI regulation and policy formation, and build strong consumer trust.
This whitepaper draws on global practices and extensive stakeholder consultations across six Asia-Pacific markets. It introduces the A-C-T (Access - Capability - Trust) framework to categorise levers by which the MedTech industry, working hand-in-hand with governments and others in the ecosystem, can address challenges in areas such as regulation, ethics, talent, infrastructure and data, cost, and socio-economic disparities.
Principal Advisor, Head of Healthcare and Life Sciences, KPMG in Singapore
KPMG in Singapore
